Home > Journals > Medicine > Médecine > summary
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
Médecine
- Current issue
- Index set of themes
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
Printable version

Year 2011 of the drug: the year of turmoil?


Médecine. Volume 8, Number 1, 11-7, Janvier 2012, Thérapeutiques

Résumé   Texte intégral  

Author(s) : Charles Caulin

Summary : The turmoil on Mediator® forces us to reconsider the assessment procedures of the drug, the missions of various French agencies such as the Afssaps and of several Health agencies, the organization of pharmacovigilance and the methods of medical information. Dozens of specialized medical fields have been or will be withdrawn. In most cases, the “new” drugs for 2011 in primary care are related to old drugs and provide little originality: there is no innovative drug. They are more numerous in certain specialties.

Keywords : pharmacology, clinical

 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]